Clinical Infectious Diseases, HIV-related health complications and treatments
Active, last published 2026
0
H-index
0
Citations
Victor has not officially claimed their profile. If you are Victor, claim it free.
Claim Your Profile01 · About the work
What I study
research summary for Victor Omodi will appear here once their profile is updated.
02 · Reach
Publication output and reach
Victor's work has been cited 0 times across 2 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
07 · Selected work
Recent publications
2024Open access3cites
Change in Blood Pressure, Weight, and Other Cardiovascular Disease Risk Factors After Switch From Protease Inhibitors to Dolutegravir: Post hoc Analysis of the 48-week Randomised Second-line Switch to Dolutegravir Trial2026Open access
The dolutegravir failure cohort: A multi-country longitudinal cohort with a randomised clinical trial of continued dolutegravir versus switch to darunavir in people with viraemia while on dolutegravir in Sub-Saharan Africa (The Ndovu Study) protocolPLoS ONE, HIV/AIDS drug development and treatment
Are you Victor?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
No commitment required